Biomarker Uprising: The Dazzling Paradigm Shift
Journal of Cellular & Molecular Anesthesia,
Vol. 7 No. 2 (2022),
5 Khordad 2022
,
Page 76-77
https://doi.org/10.22037/jcma.v7i2.38434
Abstract
- Biomarker
- Personalized Medicine
How to Cite
References
Sezari P, Dabbagh A. Personalized medicine: the paradigm shift in medicine mandating lifelong learning. J Cell Mol Anesth. 2019;4(2):31-2.
Bonnefoy JY. The biomarker revolution: a step toward personalized medicine. Per Med. 2008;5(6):553-6.
Aronson JK, Ferner RE. Biomarkers-A General Review. Curr Protoc Pharmacol. 2017;76:9.23.1-9..17.
Holliday EG, Scott RJ, Attia J. Evidence-based medicine in the era of biomarkers: teaching a new dog old tricks? Clin Pharmacol Ther. 2010;88(6):740-2.
Talischi M, Mohamadnia A, Mahmoodi M, Bahrami N, Farhadi Nasab A. Predictive Blood Biomarkers in Non Small Cell Lung Cancer. J Cell Mol Anesth. 2022;7(2):116-21.
Vargas AJ, Harris CC. Biomarker development in the precision medicine era: lung cancer as a case study. Nat Rev Cancer. 2016;16(8):525-37.
Emadi M, Soltani S, Noori B, Zandi M, Shateri Z, Tabibzadeh A, et al. Highly Conserve Sequences in Envelope, Nucleoprotein and RNA-Dependent RNA Polymerase of SARS-CoV-2 in Nasopharyngeal Samples of the COVID-19 Patients; a Diagnostic Target for Further Studies. J Cell Mol Anesth 2022;7(2):78-83.
Mansouri V, Rezaiee Tavirani M, Okhovatian F, Abbaszadeh HA. Markers in Severe COVID-19 Versus Mild COVID-19. J Cell Mol Anesth. 2022;7(2):109-15.
- Abstract Viewed: 93 times
- PDF Downloaded: 78 times